Latest News and Press Releases

EXTON, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced that physicians at one of the nation’s largest...

ERJ Open Research article reports that Glasmacinal, a novel macrolide, was well tolerated and reduced neutrophilic inflammation in COPD patients.

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years...

Lungpacer Medical today announced the first six patients enrolled in the groundbreaking STARI clinical trial.

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...

Study met primary and secondary endpointsParidiprubart demonstrated a relative reduction in the risk of death of 25%Treatment provided patients with clinically meaningful improvement in survival and...

New global RSV Alliance launched to raise awareness of RSV risks in older adults and vulnerable populations.

Monaghan Medical announces the nationwide availability of the AeroChamber2go® Valved Holding Chamber (VHC), a portable inhaler chamber and case.

The new AeroChamber2Go™ chamber combines proven inhaler therapy support with a discreet, portable design, now at Walmart Pharmacies nationwide

The Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-on Payment (NTAP) status for Lungpacer's AeroPace® System.